Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes



Rating:

Share or cite this content

Citations should be made in the following way:
A. Shoemark (Dundee, United Kingdom), M. Shteinberg (Haifa, Israel), A. De Soyza (Newcastle, United Kingdom), C. Haworth (Cambridge, United Kingdom), H. Richardson (Dundee, United Kingdom), L. Perea (Barcelona, Spain), A. Dicker ( Dundee, United Kingdom), P. Goeminne (Leuven, Belgium), E. Cant (Dundee, United Kingdom), E. Polverino (Barcelona, Spain), J. Altenburg (Amsterdam, Netherlands), H. Keir (Dundee, United Kingdom), M. Loebinger (London, United Kingdom), F. Blasi (Milan, Italy), T. Welte (Hannover, Germany), O. Sibila (Barcelona, Spain), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom). Characterisation of eosinophilic bronchiectasis: A European multicohort study. 1307

Member's Comments

No comment yet.

Related content which might interest you: Development of asthma in patients with eosinophilic bronchitis: prospective follow up study Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Features of post-tuberculosis bronchiectasis: Tunisian comparative study Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort Source: Eur Respir J, 50 (4) 1700853; 10.1183/13993003.00853-2017 Year: 2017 Research priorities in bronchiectasis: A consensus from the European multicentre bronchiectasis audit and research collaboration (EMBARC) study group Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Development of chronic airway obstructive in patients with eosinophilic bronchitis: a prospective follow up study Source: Eur Respir J 2003; 22: Suppl. 45, 423s Year: 2003 The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC) Year: 2015 Viral prevalence in stable bronchiectasis: analysis of the Cohort of Asian and Matched European Bronchiectasis (CAMEB) Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Mepolizumab is effective in severe eosinophilic asthmatics: an Austrian real-life study. Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019 Year: 2019 Omalizumab in allergic eosinophilic asthma and lung eosinophil numbers: A 78-week randomized controlled trial Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Multicentric Latin American study of 211 patients with Interstitial lung disease and myositis related antibodies Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Association of asthma diagnosis with chronic airflow obstruction: a multi-site cross-sectional study Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021 Acute fibrinous and organizing pneumonia: A retrospective study Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Asthma control and small airways disease in a French epidemiological study: the JACINTE survey Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001 Eosinophilic inflammation in COPD: prevalence and clinical characteristics Source: Eur Respir J 2014; 44: 1697-1700 Year: 2014 The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Late Breaking Abstract - Dose-ranging study of mepolizumab in eosinophilic COPD Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Mepolizumab in COPD with eosinophilic bronchitis: A randomized clinical trial Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 A clinical study of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 An observational study to characterize severe eosinophilic asthma in New Zealand Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018